Shenzhen Kangtai Biological Products Co., Ltd. Share Price
Equities
300601
CNE100002Q33
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.75 CNY | +7.01% | +4.06% | -23.57% |
Sales 2024 * | 4.81B 664M 53.15B | Sales 2025 * | 5.91B 816M 65.34B | Capitalization | 23.18B 3.2B 256B |
---|---|---|---|---|---|
Net income 2024 * | 1.34B 185M 14.84B | Net income 2025 * | 1.75B 242M 19.34B | EV / Sales 2024 * | 4.83 x |
Net Debt 2024 * | 57.28M 7.91M 633M | Net cash position 2025 * | 373M 51.47M 4.12B | EV / Sales 2025 * | 3.86 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
12.8
x | Employees | 2,018 |
Yield 2024 * |
2.06% | Yield 2025 * |
2.49% | Free-Float | 51.45% |
1 day | +7.01% | ||
1 week | +4.06% | ||
Current month | -5.21% | ||
1 month | -4.29% | ||
3 months | -9.74% | ||
6 months | -28.89% | ||
Current year | -23.57% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Zhou
DFI | Director of Finance/CFO | 52 | 29/12/21 |
Xiang Miao
PSD | President | 51 | 31/12/08 |
Wei Min Du
CHM | Chairman | 61 | 23/09/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jiao Yu Li
BRD | Director/Board Member | 66 | 28/12/21 |
Wei Min Du
CHM | Chairman | 61 | 23/09/08 |
Jian Kai Liu
BRD | Director/Board Member | 54 | 23/09/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.60% | 2 M€ | -16.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 20.75 | +7.01% | 18,007,490 |
25/04/24 | 19.39 | -0.62% | 10,420,340 |
24/04/24 | 19.51 | -1.86% | 9,911,123 |
23/04/24 | 19.88 | -1.14% | 9,383,245 |
22/04/24 | 20.11 | +0.85% | 8,987,833 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.57% | 3.2B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 300601 Stock